Episodes 61-75 of 90
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®Treat or Refer: Who Is Responsible for Managing Gout?
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®Can You Manage Patients With Uncontrolled Gout More Effectively?
What’s New About Gout? Rheumatology Perspective
MinuteCE®What’s New About Gout? Rheumatology Perspective
What Are the Emerging Therapies for Managing Gout?
MinuteCE®What Are the Emerging Therapies for Managing Gout?
Should We Look for Gout in the Cardiology Clinic?
MinuteCE®Should We Look for Gout in the Cardiology Clinic?
- advertisement
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CEDirected Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CEKALMing the Itch: Improving QoL in Patients with CKD-aP
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CEUnderstanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Separating Fact from Fiction: The Realities of CKD-aP
CME/CESeparating Fact from Fiction: The Realities of CKD-aP
- advertisement
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CESecondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
